Stanley Chang
Chief Executive Officer at MEDIGEN BIOTECHNOLOGY CORP.
Stanley Chang active positions
Companies | Position | Start | End |
---|---|---|---|
TBG DIAGNOSTICS LIMITED | Director/Board Member | - | - |
MEDIGEN BIOTECHNOLOGY CORP. | Chief Executive Officer | 2003-06-08 | - |
Chairman | 2003-06-08 | - | |
MEDIGEN VACCINE BIOLOGICS CORPORATION | Chairman | 2012-12-11 | - |
Chief Executive Officer | 2014-12-22 | 2016-11-16 | |
WINSTON MEDICAL SUPPLY CO., LTD. | Chairman | 2014-02-06 | - |
TBG Biotechnology, Inc. | Director/Board Member | - | - |
UMO International Co., Ltd. | Director/Board Member | - | - |
TBG, Inc. (Taiwan)
TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Director/Board Member | - | - |
Career history of Stanley Chang
Former positions of Stanley Chang
Companies | Position | Start | End |
---|---|---|---|
Ameribankers Corp. | President | - | 1999-12-31 |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Director/Board Member | 2011-07-10 | - |
░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Stanley Chang
University College London | Doctorate Degree |
National Taiwan University College of Medicine | Undergraduate Degree |
Statistics
International
Taiwan | 10 |
Australia | 2 |
United Kingdom | 2 |
Operational
Director/Board Member | 6 |
Chairman | 3 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 4 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
MEDIGEN BIOTECHNOLOGY CORP. | Health Technology |
WINSTON MEDICAL SUPPLY CO., LTD. | Health Technology |
MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
Private companies | 7 |
---|---|
TBG Diagnostics Ltd.
TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
TBG, Inc. (Taiwan)
TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Finance |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Health Services |
Ameribankers Corp. | |
Medigreen Biotechnology Corp.
Medigreen Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Medigreen Biotechnology Corporation, founded on April 10th, 2002, is focusing on the development of botanical new drugs and is established by domestic and overseas outstanding enterprises and entrepreneurs, in accordance with the government's promotion policy, to develop the Chinese Traditional Medicine industry. The major stockholders of Medigreen include Medigen Biotechnology Corp., SunTen Phytotech Co., Ltd. and YFY Biotech Management Company, etc. Since the foundation, based on the mission of 'contribution to the human health' and on the main principle of the immunologic system, Medigreen has been worked on the R & D of new botanical drugs on 'cancer adjuvant', 'anti-ulcer' and 'respiratory tract diseases'. Medigreen develops diverse functional products and ingredients on the base of the Traditional Chinese Medicine theory, the concept of 'medicine and food from the same source', and the efficacy examination of biotechnology followed the new drug development process to contribute to the human health and to guarantee the persistent progress of the enterprise during the new drug development. | Health Technology |
TBG Biotechnology, Inc. | |
UMO International Co., Ltd. |
- Stock Market
- Insiders
- Stanley Chang
- Experience